Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 406

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 406
---
 Trust Account, if any. The proceeds of the note will be used by Iris for working capital purposes. As of September 30, 2024, Iris’s outstanding balance was $613,720 under this loan.

#### Related Party Loans
In addition, in order to fund working capital deficiencies or finance transaction costs in connection with an intended business combination, the Sponsor or an affiliate of the Sponsor, or certain of Iris’s officers and directors may, but are not obligated to, loan Iris funds as may be required on a non-interest bearing basis (“Working Capital Loans”). If Iris completes the initial business combination, Iris would repay the Working Capital Loans. In the event that the initial business combination does not close, Iris may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans, but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-business combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the Private Warrants. As of September 30, 2024, Iris had no borrowings under the Working Capital Loans.

#### Administrative Support Agreement
Subsequent to the closing of the IPO, the Company began paying an affiliate of the Sponsor, Tribe Capital, $10,000 per month for office space, secretarial and administrative services provided to members of the Company’s management team. For the years ended December 31, 2023 and 2022, payments totaled $0 and $50,000, respectively, which are included in formation and operating costs on the statements of operations. As of September 30, 2024 and December 31, 2023, there is a due to related party within the balance sheets in the amount of $75,000 owed to the Sponsor to pay for consulting services on behalf of the Company.

On June 1, 2022, Tribe Capital withdrew as a member of the Sponsor. In conjunction with its withdrawal as a member, Tribe Capital resigned as the managing member of the Sponsor effective June 1, 2022. Members holding a majority of the membership interest in the Sponsor appointed Arrow Multi Asset Fund — Arrow SP6 (“Arrow”) as the managing member of the Sponsor effective June 1, 2022. Following the withdrawal of Tribe Capital as a member of the Sponsor, the $140,000 of administrative expense payable as of June 1